Market research
7SO.F SuperSonic Imagine SA
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 35M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.1
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- Not available
- Market cap
- 35M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.1
About
About SuperSonic Imagine SA
SuperSonic Imagine SA operates as a medical technology company. The company designs, develops, and markets Aixplorer, an ultrasound system that renders images with exceptional definition, contrast, and resolution; and Aixplorer MACH ultrasound machines. It has developed a technology that offers practitioners and patients a breakthrough in the diagnosis and follow up of breast, prostate, and thyroid cancers, as well as liver diseases. The company serves China, the United States, France, Asia, and the Europe, Middle East, and Africa. The company was founded in 2005 and is headquartered in Aix-en-Provence, France. SuperSonic Imagine SA is a subsidiary of Hologic Hub Ltd.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 7SO.F discussion.
5 years, 5 months ago
SuperSonic Imagine SA is currently in a long term uptrend where the price is trading 5.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.1.
Finally, its free cash flow grew by 36.7% to $-3M since the same quarter in the previous year.
Based on the above factors, SuperSonic Imagine SA gets an overall score of 3/5.